Ascites Is a Poor Prognostic Factor in Advanced Pancreatic Adenocarcinoma and May Be Undertreated: A Prospective Cohort Study.
Justin WangYujie CuiArsen OsipovJun GongStephen PandolSimon LoNicholas NissenAnser AbbasAbrahm LeviAndrew HendifarPublished in: Clinical and translational gastroenterology (2024)
The use of diuretics is lower than would be expected for patients with pancreatic ductal adenocarcinoma with elevated serum-ascites albumin gradient. Other therapies such as beta blockers should be investigated in this subset of patients. The etiology of ascites in these patients is poorly understood, and further research is needed to establish treatment guidelines and improve outcomes.